Sequenced treatment alternatives to relieve depression (STAR*D): rationale and designA. John Rush, Frederic M. Quitkin, T. Michael Kashner et al.|Controlled Clinical Trials|2004Cited by 1.1k
Why Do Clinical Trials Fail?Kenneth A. Kobak, Andrew A. Nierenberg, John Kane et al.|Journal of Clinical Psychopharmacology|2007Cited by 114
Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depressionMichael E. Thase, John H. Simmons, Andrew A. Nierenberg et al.|International Clinical Psychopharmacology|2010Cited by 90
Efficacy of Mirtazapine for Prevention of Depressive RelapseMichael E. Thase, Andrew A. Nierenberg, Martín Keller|The Journal of Clinical Psychiatry|2001Cited by 86
What predicts attrition in second step medication treatments for depression?: a STAR*D ReportDiane Warden, Madhukar H. Trivedi, A. John Rush et al.|The International Journal of Neuropsychopharmacology|2008Cited by 79